Dr Misghina Weldegiorgis

Dr Misghina Weldegiorgis

Adjunct Professor

2012 - 2017    PhD, University of Groningen, dissertation title "Evaluation of renal endpoints in nephrology trials" 

2010 - 2014    MSc in Pharmacoepidemiology, Utrecht University, dissertation title "Pharmacogenetics of aspirin in secondary acute coronary syndromes"

2002 - 2008    BSc in Pharmacy, University of Asmara, dissertation title "Prevalence and treatment of breast cancer in Asmara"

Medicine & Health
School of Population Health

Dr. Weldegiorgis is a conjoint lecturer at the University of New South Wales Sydney, a Postdoctoral Research Associate at Imperial College London, and an Honorary Research Fellow at The George Institute for Global Health. His main research interest is in the epidemiology of chronic diseases. His current research project assesses risk factors and pathways to the dominant forms of multiple long-term chronic conditions (multi-morbidities) using ‘Big Data’.

Previously, he held a Postdoctoral Epidemiologist position at the University of Oxford, where his research projects investigate modifiable social and clinical risk factors associated with the development and progression of chronic kidney diseases.

He completed his BSc degree in pharmacy from the University of Asmara and then worked as a pharmacist at the National Referral Hospital and the Ministry of Health, Eritrea, prior to relocating to the Netherlands to pursue his research interest. He was awarded MSc scholarship by the Dutch Ministry of Education, Culture & Science, and he completed his MSc degree in epidemiology (specialized in pharmacoepidemiology) at Utrecht University. Subsequently, he was awarded PhD fellowship by the Groningen University Institute for Drug Exploration (GUIDE) and completed his doctoral degree in ‘Evaluation of renal endpoints in nephrology trials’. 

Department of Epidemiology and Biostatistics | School of Public Health | Imperial College London | St Mary’s Campus | Norfolk Place | London W2 1PG | United Kingdom
  • Journal articles | 2022
    Weldegiorgis M; Woodward M, 2022, 'Correction: Elevated triglycerides and reduced high-density lipoprotein cholesterol are independently associated with the onset of advanced chronic kidney disease: a cohort study of 911,360 individuals from the United Kingdom (BMC Nephrology, (2022), 23, 1, (312), 10.1186/s12882-022-02932-2)', BMC Nephrology, 23, http://dx.doi.org/10.1186/s12882-022-02948-8
    Journal articles | 2022
    Weldegiorgis M; Woodward M, 2022, 'Elevated triglycerides and reduced high-density lipoprotein cholesterol are independently associated with the onset of advanced chronic kidney disease: a cohort study of 911,360 individuals from the United Kingdom', BMC Nephrology, 23, pp. 312, http://dx.doi.org/10.1186/s12882-022-02932-2
    Journal articles | 2021
    Gregg EW; Sophiea MK; Weldegiorgis M, 2021, 'Diabetes and covid-19: Population impact 18 months into the pandemic', Diabetes Care, 44, pp. 1916 - 1923, http://dx.doi.org/10.2337/dci21-0001
    Journal articles | 2021
    Ismail S; Odland ML; Malik A; Weldegiorgis M; Newbigging K; Peden M; Woodward M; Davies J, 2021, 'The relationship between psychosocial circumstances and injuries in adolescents: An analysis of 87,269 individuals from 26 countries using the Global School-based Student Health Survey', PLoS Medicine, 18, pp. e1003722, http://dx.doi.org/10.1371/journal.pmed.1003722
    Journal articles | 2021
    Neuen BL; Weldegiorgis M; Herrington WG; Ohkuma T; Smith M; Woodward M, 2021, 'Changes in GFR and Albuminuria in Routine Clinical Practice and the Risk of Kidney Disease Progression', American Journal of Kidney Diseases, 78, pp. 350 - 360.e1, http://dx.doi.org/10.1053/j.ajkd.2021.02.335
    Journal articles | 2020
    Weldegiorgis M; Smith M; Herrington WG; Bankhead C; Woodward M, 2020, 'Socioeconomic disadvantage and the risk of advanced chronic kidney disease: Results from a cohort study with 1.4 million participants', Nephrology Dialysis Transplantation, 35, pp. 1562 - 1570, http://dx.doi.org/10.1093/ndt/gfz059
    Journal articles | 2020
    Weldegiorgis M; Woodward M, 2020, 'Correction to: The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis (BMC Nephrology, (2020), 21, 1, (506), 10.1186/s12882-020-02151-7)', BMC Nephrology, 21, http://dx.doi.org/10.1186/s12882-020-02199-5
    Journal articles | 2020
    Weldegiorgis M; Woodward M, 2020, 'The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis', BMC Nephrology, 21, http://dx.doi.org/10.1186/s12882-020-02151-7
    Journal articles | 2019
    Coresh J; Heerspink HJL; Sang Y; Matsushita K; Arnlov J; Astor BC; Black C; Brunskill NJ; Carrero JJ; Feldman HI; Fox CS; Inker LA; Ishani A; Ito S; Jassal S; Konta T; Polkinghorne K; Romundstad S; Solbu MD; Stempniewicz N; Stengel B; Tonelli M; Umesawa M; Waikar SS; Wen CP; Wetzels JFM; Woodward M; Grams ME; Kovesdy CP; Levey AS; Gansevoort RT; Appel LJ; Greene T; Chen TK; Chalmers J; Arima H; Perkovic V; Levin A; Djurdjev O; Tang M; Nally J; Navaneethan SD; Schold JD; Weldegiorgis M; Herrington WG; Smith M; Hsu CY; Hwang SJ; Chang AR; Kirchner HL; Green JA; Ho K; Marks A; Prescott G; Clark LE; Fluck N; Shalev V; Chodick G; Blankestijn PJ; Van Zuilen A; Van den Brand JA; Sarnak MJ; Bottinger E; Nadkarni GN; Ellis SG; Nadukuru R; Metzger M; Flamant M; Houillier P; Haymann JP; Froissart M; Kenealy T; Elley RC; Collins JF; Drury PL; Cuddeback JK; Ciemins EL; Stempniewicz R; Nelson RG; Knowler WC; Bakker SJ; Major RW; Medcalf JF; Shepherd D; Barrett-Connor E; Bergstrom J; Ix JH; Molnar MZ; Sumida K; de Zeeuw D; Brenner B; Qureshi AR; Elinder CG; Runesson B; Evans M; Segelmark M; Stendahl M; Schön S; Naimark DM; Tangri N, 2019, 'Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies', The Lancet Diabetes and Endocrinology, 7, pp. 115 - 127, http://dx.doi.org/10.1016/S2213-8587(18)30313-9
    Journal articles | 2018
    Smith M; Herrington WG; Weldegiorgis M; Hobbs FR; Bankhead C; Woodward M, 2018, 'Change in Albuminuria and Risk of Renal and Cardiovascular Outcomes: Natural Variation Should Be Taken into Account', Kidney International Reports, 3, pp. 939 - 949, http://dx.doi.org/10.1016/j.ekir.2018.04.004
    Journal articles | 2018
    Weldegiorgis M; de Zeeuw D; Li L; Parving HH; Hou FF; Remuzzi G; Greene T; Heerspink HJL, 2018, 'Longitudinal Estimated GFR Trajectories in Patients With and Without Type 2 Diabetes and Nephropathy', American Journal of Kidney Diseases, 71, pp. 91 - 101, http://dx.doi.org/10.1053/j.ajkd.2017.08.010
    Journal articles | 2017
    Weldegiorgis M; de Zeeuw D; Dwyer JP; Mol P; Heerspink HJL, 2017, 'Is chronic dialysis the right hard renal end point to evaluate renoprotective drug effects?', Clinical Journal of the American Society of Nephrology, 12, pp. 1595 - 1600, http://dx.doi.org/10.2215/CJN.09590916
    Journal articles | 2015
    Weldegiorgis M; De Zeeuw D; Heerspink HJL, 2015, 'Renal end points in clinical trials of kidney disease', Current Opinion in Nephrology and Hypertension, 24, pp. 284 - 289, http://dx.doi.org/10.1097/MNH.0000000000000118
    Journal articles | 2014
    Lambers Heerspink HJ; Weldegiorgis M; Inker LA; Gansevoort R; Parving HH; Dwyer JP; Mondal H; Coresh J; Greene T; Levey AS; De Zeeuw D, 2014, 'Estimated GFR decline as a surrogate end point for kidney failure: A post hoc analysis from the reduction of end points in non-insulin-dependent diabetes with the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT)', American Journal of Kidney Diseases, 63, pp. 244 - 250, http://dx.doi.org/10.1053/j.ajkd.2013.09.016
    Journal articles | 2013
    Weldegiorgis M; de Zeeuw D; Greene T; Li L; Rossing P; Smink P; Heerspink HL, 2013, 'PS11 - 1. Longitudinal eGFR trajectories in patients with type 2 diabetes', Nederlands Tijdschrift voor Diabetologie, 11, pp. 162 - 162, http://dx.doi.org/10.1007/s12467-013-0107-6
  • Conference Papers | 2021
    Sutradhar I; Ikpeme M; Weldegiorgis M; Hasan M; Mridha MK; Sarker M; Gregg E, 2021, 'Prevalence and control status of T2DM in Bangladesh: finding from a nationally representative survey', in EUROPEAN JOURNAL OF PUBLIC HEALTH, OXFORD UNIV PRESS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000713802500256&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
    Conference Abstracts | 2020
    Neuen B; Weldegiorgis M; Herrington W; Okhuma T; Smith M; Woodward M, 2020, 'COMBINED CHANGES IN GLOMERULAR FILTRATION RATE AND ALBUMINURIA AND RISK OF KIDNEY DISEASE PROGRESSION IN ROUTINE CLINICAL PRACTICE', in NEPHROLOGY, WILEY, Vol. 25, pp. 23 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000592647200053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1